The field is expanding quickly, and often without clear rules. Though the FDA has approved one ketamine-based nasal spray for depression, most clinics offer intravenous infusions of ketamine, an ...

Hyderabad-based Mapmygenome’s acquisition of Canada’s Microbiome Insights marks a critical moment in healthcare. It provides ...